Dennis Rottländer1, MD; Thorsten Schneider1, MD; Hubertus Degen1, MD; Mathias Laufenberg1, MD; Martijn Chatrou2, PhD; Michael Haude1, MD
1. Department of Cardiology, Städtische Kliniken Neuss, Neuss, Germany; 2. Pie Medical Imaging BV, Maastricht, the Netherlands
The Carillon® Mitral Contour System® (Cardiac Dimensions, Kirkland, WA, USA) for coronary sinus (CS)-based percutaneous mitral valve repair has demonstrated a reduction in functional mitral valve regurgitation (FMR) in heart failure patients1,2. However, an acute reduction in FMR determined by echocardiography cannot be achieved in all patients: the AMADEUS trial reported that there was no acute effect on FMR in 18.6% of the patients2. However, three-dimensional (3D) imaging modalities for percutaneous valve interventions have been implemented in clinical routine. For example, multislice computed tomography (MSCT) is pivotal for procedural planning of transcatheter aortic valve implantation (...